Table: Shin Nippon Biomedical -Q1 group results

Shin Nippon Biomedical Laboratories

29/07/2022 07:00

Jul 29 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             4.05                3.04             22.83    
                 (+33.1 pct)         (-4.2 pct)       (+28.6 pct) 
  Operating        714 mln             491 mln            5.21    
                 (+45.2 pct)         (+9.9 pct)       (+24.2 pct) 
  Recurring         2.77               672 mln            7.89    
                (+312.1 pct)         (-8.1 pct)       (+11.5 pct) 
  Net               1.94                1.83              5.59    
                 (+6.5 pct)         (+183.9 pct)      (-21.5 pct) 
  EPS             46.70 yen           43.87 yen       134.27 yen  
  Ann Div                             40.00 yen        40.00 yen  
  -Q2 div                                NIL           20.00 yen  
  -Q4 div                             40.00 yen        20.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T